
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $24K | $51.8M | $60.9M | $377.7M | $63.5M | |
Revenue Growth (YoY) | 33.33% | 215916.67% | 17.51% | 520.01% | -83.18% | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $103.2M | $387.1M | $311.6M | $437.4M | $367.6M | |
Selling, General & Admin | $29.6M | $57.2M | $87.8M | $116.8M | $111.5M | |
Other Inc / (Exp) | -$62.9M | $21.8M | $63M | -$1.4M | -$10.2M | |
Operating Expenses | $132.8M | $444.3M | $399.4M | $554.2M | $479.1M | |
Operating Income | -$132.8M | -$392.5M | -$338.5M | -$176.5M | -$415.6M | |
Net Interest Expenses | -- | $9K | -- | -- | -- | |
EBT. Incl. Unusual Items | -$194.6M | -$370.6M | -$260.2M | -$131.2M | -$376.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | $3.4M | $1.4M | $39K | |
Net Income to Company | -$194.6M | -$370.6M | -$289.1M | -$132.5M | -$376.7M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$194.6M | -$370.6M | -$289.1M | -$132.5M | -$376.7M | |
Basic EPS (Cont. Ops) | -$4.19 | -$5.77 | -$4.13 | -$1.72 | -$4.58 | |
Diluted EPS (Cont. Ops) | -$4.19 | -$5.77 | -$4.13 | -$1.72 | -$4.58 | |
Weighted Average Basic Share | $46.7M | $64.2M | $70M | $77.2M | $82.3M | |
Weighted Average Diluted Share | $46.7M | $64.2M | $70M | $77.2M | $82.3M | |
EBITDA | -$128M | -$385M | -$315.9M | -$147M | -$384M | |
EBIT | -$132.8M | -$392.5M | -$338.5M | -$176.5M | -$415.6M | |
Revenue (Reported) | $24K | $51.8M | $60.9M | $377.7M | $63.5M | |
Operating Income (Reported) | -$132.8M | -$392.5M | -$338.5M | -$176.5M | -$415.6M | |
Operating Income (Adjusted) | -$132.8M | -$392.5M | -$338.5M | -$176.5M | -$415.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $6K | $8.4M | $24.2M | $7.4M | $7.5M | |
Revenue Growth (YoY) | -- | 140433.33% | 187.1% | -69.39% | 0.81% | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $190.1M | $65.4M | $99.6M | $84.8M | $98.8M | |
Selling, General & Admin | $10.3M | $19.2M | $23.5M | $26.7M | $27.9M | |
Other Inc / (Exp) | -$1.2M | $6.4M | -$7.5M | -$6.4M | $152K | |
Operating Expenses | $200.4M | $84.7M | $123.1M | $111.5M | $126.8M | |
Operating Income | -$200.4M | -$76.2M | -$98.9M | -$104.1M | -$119.3M | |
Net Interest Expenses | $21K | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$201.6M | -$69.2M | -$96.5M | -$98.7M | -$109.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$201.6M | -$69.2M | -$96.5M | -$98.7M | -$109.3M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$201.6M | -$69.2M | -$96.5M | -$98.7M | -$109.3M | |
Basic EPS (Cont. Ops) | -$3.35 | -$1.01 | -$1.33 | -$1.21 | -$1.24 | |
Diluted EPS (Cont. Ops) | -$3.35 | -$1.01 | -$1.33 | -$1.21 | -$1.24 | |
Weighted Average Basic Share | $60.2M | $68.7M | $72.3M | $81.7M | $88M | |
Weighted Average Diluted Share | $60.2M | $68.7M | $72.3M | $81.7M | $88M | |
EBITDA | -$199M | -$72.9M | -$94.3M | -$98.7M | -$113.8M | |
EBIT | -$200.4M | -$76.2M | -$98.9M | -$104.1M | -$119.3M | |
Revenue (Reported) | $6K | $8.4M | $24.2M | $7.4M | $7.5M | |
Operating Income (Reported) | -$200.4M | -$76.2M | -$98.9M | -$104.1M | -$119.3M | |
Operating Income (Adjusted) | -$200.4M | -$76.2M | -$98.9M | -$104.1M | -$119.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $24K | $60.3M | $76.7M | $360.9M | $63.6M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $271.7M | $262.4M | $345.8M | $422.6M | $381.6M | |
Selling, General & Admin | $33.1M | $66.2M | $92M | $120M | $112.7M | |
Other Inc / (Exp) | -$61.3M | $29.4M | $49.1M | -$245K | -$3.7M | |
Operating Expenses | $304.8M | $328.6M | $437.9M | $542.6M | $494.3M | |
Operating Income | -$304.8M | -$268.3M | -$361.2M | -$181.7M | -$430.7M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$365.7M | -$238.3M | -$287.4M | -$133.4M | -$387.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$365.7M | -$238.3M | -$316.3M | -$134.7M | -$387.3M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$365.7M | -$238.3M | -$316.3M | -$134.7M | -$387.3M | |
Basic EPS (Cont. Ops) | -$6.61 | -$3.61 | -$4.45 | -$1.74 | -$4.61 | |
Diluted EPS (Cont. Ops) | -$6.61 | -$3.61 | -$4.45 | -$1.78 | -$4.61 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$299.7M | -$259M | -$337.3M | -$151.4M | -$399M | |
EBIT | -$304.8M | -$268.3M | -$361.2M | -$181.7M | -$430.7M | |
Revenue (Reported) | $24K | $60.3M | $76.7M | $360.9M | $63.6M | |
Operating Income (Reported) | -$304.8M | -$268.3M | -$361.2M | -$181.7M | -$430.7M | |
Operating Income (Adjusted) | -$304.8M | -$268.3M | -$361.2M | -$181.7M | -$430.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $6K | $8.4M | $24.2M | $7.4M | $7.5M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $190.1M | $65.4M | $99.6M | $84.8M | $98.8M | |
Selling, General & Admin | $10.3M | $19.2M | $23.5M | $26.7M | $27.9M | |
Other Inc / (Exp) | -$1.2M | $6.4M | -$7.5M | -$6.4M | $152K | |
Operating Expenses | $200.4M | $84.7M | $123.1M | $111.5M | $126.8M | |
Operating Income | -$200.4M | -$76.2M | -$98.9M | -$104.1M | -$119.3M | |
Net Interest Expenses | $21K | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$201.6M | -$69.2M | -$96.5M | -$98.7M | -$109.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$201.6M | -$69.2M | -$96.5M | -$98.7M | -$109.3M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$201.6M | -$69.2M | -$96.5M | -$98.7M | -$109.3M | |
Basic EPS (Cont. Ops) | -$3.35 | -$1.01 | -$1.33 | -$1.21 | -$1.24 | |
Diluted EPS (Cont. Ops) | -$3.35 | -$1.01 | -$1.33 | -$1.21 | -$1.24 | |
Weighted Average Basic Share | $60.2M | $68.7M | $72.3M | $81.7M | $88M | |
Weighted Average Diluted Share | $60.2M | $68.7M | $72.3M | $81.7M | $88M | |
EBITDA | -$199M | -$72.9M | -$94.3M | -$98.7M | -$113.8M | |
EBIT | -$200.4M | -$76.2M | -$98.9M | -$104.1M | -$119.3M | |
Revenue (Reported) | $6K | $8.4M | $24.2M | $7.4M | $7.5M | |
Operating Income (Reported) | -$200.4M | -$76.2M | -$98.9M | -$104.1M | -$119.3M | |
Operating Income (Adjusted) | -$200.4M | -$76.2M | -$98.9M | -$104.1M | -$119.3M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $162.2M | $560M | $232.8M | $435.9M | $282M | |
Short Term Investments | $137.5M | $405.7M | $845.4M | $754M | $568.8M | |
Accounts Receivable, Net | -- | $300M | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $8.7M | -- | -- | -- | -- | |
Other Current Assets | -- | $7.4M | $14.8M | $21.2M | $27.4M | |
Total Current Assets | $308.3M | $1.3B | $1.1B | $1.2B | $878.1M | |
Property Plant And Equipment | $125.4M | $187M | $234.1M | $237.8M | $216.3M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $18M | $14.5M | $14.7M | $10.9M | $9.4M | |
Total Assets | $451.7M | $1.5B | $1.3B | $1.5B | $1.1B | |
Accounts Payable | $6.3M | $7.5M | $9M | $1.6M | $3.9M | |
Accrued Expenses | $6.6M | $49M | $18.5M | $61.2M | $18.1M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $4.2M | $7.5M | $10.4M | $12.8M | $13.5M | |
Other Current Liabilities | $77.5M | $51.5M | $30.6M | $39.4M | $16.2M | |
Total Current Liabilities | $102.3M | $213.4M | $223.6M | $205.6M | $182.1M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $206.1M | $647.7M | $608.2M | $478.4M | $370.3M | |
Common Stock | $573K | $684K | $712K | $816K | $836K | |
Other Common Equity Adj | -$9K | -$50K | -$2.4M | $604K | $679K | |
Common Equity | $245.6M | $826.7M | $733.5M | $981.3M | $733.5M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $245.6M | $826.7M | $733.5M | $981.3M | $733.5M | |
Total Liabilities and Equity | $451.7M | $1.5B | $1.3B | $1.5B | $1.1B | |
Cash and Short Terms | $299.7M | $965.6M | $1.1B | $1.2B | $850.7M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $97.2M | $296.8M | $249.8M | $287.8M | $527.9M | |
Short Term Investments | $406.2M | $925.8M | $809.7M | $806.7M | $692M | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $11.1M | $16.9M | -- | -- | -- | |
Other Current Assets | -- | -- | $23.6M | $27.2M | $27.7M | |
Total Current Assets | $514.6M | $1.2B | $1.1B | $1.1B | $1.2B | |
Property Plant And Equipment | $158.8M | $199.8M | $238M | $229.9M | $211.8M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $19.9M | $14.1M | $11.3M | $8.1M | $7.5M | |
Total Assets | $693.2M | $1.5B | $1.3B | $1.4B | $1.5B | |
Accounts Payable | $8M | $6.3M | $14.1M | $2.8M | $7.7M | |
Accrued Expenses | $8.3M | $45.5M | $21.1M | $54.5M | $21.3M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $3.9M | $9.4M | $11.2M | $12.2M | $13.2M | |
Other Current Liabilities | $80.1M | $35.8M | $25.2M | $40.7M | $8.6M | |
Total Current Liabilities | $102.1M | $218.8M | $219.9M | $187.2M | $141.5M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $270.8M | $624.3M | $570.8M | $446.3M | $343.8M | |
Common Stock | $617K | $698K | $744K | $823K | $1M | |
Other Common Equity Adj | -$24K | -$2.7M | -$765K | -$921K | $160K | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $422.4M | $829.1M | $761.5M | $913.5M | $1.1B | |
Total Liabilities and Equity | $693.2M | $1.5B | $1.3B | $1.4B | $1.5B | |
Cash and Short Terms | $503.5M | $1.2B | $1.1B | $1.1B | $1.2B | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$194.6M | -$370.6M | -$289.1M | -$132.5M | -$376.7M | |
Depreciation & Amoritzation | $4.7M | $7.5M | $22.6M | $29.5M | $31.6M | |
Stock-Based Compensation | $15.4M | $43.6M | $84.3M | $98.6M | $120.7M | |
Change in Accounts Receivable | -- | -$300M | $300M | -$146K | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$95.7M | -$66.3M | $22.5M | -$149.2M | -$347.2M | |
Capital Expenditures | $16.4M | $46.8M | $49M | $33.7M | $8.9M | |
Cash Acquisitions | -- | $620K | -- | -- | -- | |
Cash From Investing | -$100.1M | -$294.1M | -$461.3M | $71.8M | $185M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $3.3M | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$1.6M | -$2.1M | -$2.3M | -$2.3M | -$485K | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$2.1M | -$8.8M | -$188K | -$631K | -- | |
Cash From Financing | $322.3M | $756.1M | $111.6M | $276.4M | $7.7M | |
Beginning Cash (CF) | $50.6M | $177M | $572.7M | $245.5M | $444.6M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $126.5M | $395.7M | -$327.2M | $199.1M | -$154.5M | |
Ending Cash (CF) | $177M | $572.7M | $245.5M | $444.6M | $290.1M | |
Levered Free Cash Flow | -$112.1M | -$113.1M | -$26.4M | -$182.9M | -$356.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$201.6M | -$69.2M | -$96.5M | -$98.7M | -$109.3M | |
Depreciation & Amoritzation | $1.4M | $3.3M | $4.6M | $5.4M | $5.5M | |
Stock-Based Compensation | $4.6M | $18M | $23.9M | $29.3M | $26.7M | |
Change in Accounts Receivable | -- | $300M | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$38.6M | $218.5M | -$109.8M | -$99.7M | -$103.9M | |
Capital Expenditures | $11.5M | $7.3M | $6M | $2.4M | $3.1M | |
Cash Acquisitions | $620K | -- | -- | -- | -- | |
Cash From Investing | -$279.6M | -$537.3M | $25.5M | -$53.5M | -$125.1M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$529K | -$553K | -$603K | -$177K | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$8M | -$6K | -$62K | -- | -- | |
Cash From Financing | $253.3M | $55.7M | $98.4M | $2.9M | $473.4M | |
Beginning Cash (CF) | $177M | $572.7M | $245.5M | $444.6M | $290.1M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$64.9M | -$263.2M | $14.1M | -$150.3M | $244.4M | |
Ending Cash (CF) | $112.1M | $309.6M | $259.6M | $294.3M | $534.5M | |
Levered Free Cash Flow | -$50.1M | $211.2M | -$115.8M | -$102.2M | -$106.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$365.7M | -$238.3M | -$316.3M | -$134.7M | -$387.3M | |
Depreciation & Amoritzation | $5M | $9.4M | $23.9M | $30.3M | $31.7M | |
Stock-Based Compensation | $17.2M | $57M | $90.2M | $104M | $118.1M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$106.9M | $190.8M | -$305.8M | -$139.1M | -$351.4M | |
Capital Expenditures | $24.8M | $42.6M | $47.7M | $30.2M | $9.6M | |
Cash Acquisitions | $620K | -- | -- | -- | -- | |
Cash From Investing | -$303M | -$551.9M | $101.5M | -$7.1M | $113.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$1.8M | -$2.1M | -$2.3M | -$1.8M | -$308K | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$9.1M | -$867K | -$244K | -- | -- | |
Cash From Financing | $382.6M | $558.5M | $154.3M | $180.9M | $478.2M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$27.3M | $197.5M | -$50M | $34.7M | $240.2M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$131.7M | $148.2M | -$353.5M | -$169.3M | -$361M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$201.6M | -$69.2M | -$96.5M | -$98.7M | -$109.3M | |
Depreciation & Amoritzation | $1.4M | $3.3M | $4.6M | $5.4M | $5.5M | |
Stock-Based Compensation | $4.6M | $18M | $23.9M | $29.3M | $26.7M | |
Change in Accounts Receivable | -- | $300M | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$38.6M | $218.5M | -$109.8M | -$99.7M | -$103.9M | |
Capital Expenditures | $11.5M | $7.3M | $6M | $2.4M | $3.1M | |
Cash Acquisitions | $620K | -- | -- | -- | -- | |
Cash From Investing | -$279.6M | -$537.3M | $25.5M | -$53.5M | -$125.1M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$529K | -$553K | -$603K | -$177K | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$8M | -$6K | -$62K | -- | -- | |
Cash From Financing | $253.3M | $55.7M | $98.4M | $2.9M | $473.4M | |
Beginning Cash (CF) | $177M | $572.7M | $245.5M | $444.6M | $290.1M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$64.9M | -$263.2M | $14.1M | -$150.3M | $244.4M | |
Ending Cash (CF) | $112.1M | $309.6M | $259.6M | $294.3M | $534.5M | |
Levered Free Cash Flow | -$50.1M | $211.2M | -$115.8M | -$102.2M | -$106.9M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.